Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triam 10 mg Lichtenstein vs Volon A 10 for intralesional treatment of keloids
2006-002003-14Phase 4Completed
- Sponsor
- Winthrop Arzneimittel
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of triamcinolone in keloid (2 arms), sponsored by Winthrop Arzneimittel. Primary endpoint: Clinical appearance of keloid scars. Started Sep 2006; status: completed.
02
Drugs
triamcinolone
03
Conditions
keloid
Beyond the preview
Go deeper on 2006-002003-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002003-14.